Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312791881> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W4312791881 endingPage "1151" @default.
- W4312791881 startingPage "1144" @default.
- W4312791881 abstract "Background: Lupus nephritis is one of complication of systemic lupus erythematosus (SLE) which manifests to the kidneys. Lupus nephritis occur in 50-60% of cases in the first ten years of the onset of SLE. Standard therapy for lupus nephritis are immunosuppressive drugs such as corticosteroids and cytostatics. In a refracter case, biologic agent has giving new hope.Case description: We report a case of seventeen years old female with chief complaints of edema in both feet, skin rash caused by sun exposure, joint pain, mouth ulcer with positive ANA test, proteinuria and high blood sugar level. Patient was then diagnosed with SLE, lupus nephritis and other types of DM. Patient was treated with combination theraphy of cycloposphamide and Rituximab. Patient then discharged in good condition.Conclusion: we suggest that combination of cycloposphamide and Rituximab is effective in controlling SLE and reducing the dose of steroid theraphy.Keyword: biological agents, systemic lupus erythematosus, lupus nephritis Latar belakang: Lupus nephritis merupakan salah satu komplikasi penyakit Systemic Lupus Erythematosus (SLE) yang bermanifestasi ke ginjal. Komplikasi lupus nephritis terjadi pada 50-60% kasus dalam sepuluh tahun pertama onset penyakit SLE. Terapi lupus nephritis meliputi obat-obatan imunosupresif seperti kortikosteroid dan sitostatika. Pada kasus-kasus yang refrakter, terapi dengan agen biologis memberikan harapan baru. Harapan hidup jangka panjang dan renal survival pasien SLE dengan lupus nephritis secara progresif telah mengalami peningkatan sejak ditemukannya agen biologis, rujukan yang lebih dini, dan kriteria diagnostik yang lebih baik.Deskripsi kasus:Kami melaporkan kasus seorang perempuan, berusia 17 tahun, suku Timor, datang dengan keluhan utama bengkak pada kedua punggung kaki, kemerahan pada kulit bila terkena sinar matahari, nyeri sendi, ulserasi pada mulut, dengan hasil laboratorium ANA test positif, proteinuria, disertai kadar gula darah yang tinggi. Pasien didiagnosis dengan SLE, lupus nephritis, dan DM Tipe lain. Setelah diberikan terapi cycloposphamide dan Rituximab, kondisi pasien membaik. Kesimpulan: regimen terapi ini efektif untuk mengontrol penyakit SLE dan memungkinkan untuk penurunan dosis terapi steroid." @default.
- W4312791881 created "2023-01-05" @default.
- W4312791881 creator A5022017205 @default.
- W4312791881 creator A5032119770 @default.
- W4312791881 creator A5062268518 @default.
- W4312791881 date "2020-12-01" @default.
- W4312791881 modified "2023-10-12" @default.
- W4312791881 title "Keberhasilan Terapi Rituximab pada Seorang Pasien dengan Lupus Nephritis Berat: Laporan Kasus" @default.
- W4312791881 doi "https://doi.org/10.15562/ism.v11i3.631" @default.
- W4312791881 hasPublicationYear "2020" @default.
- W4312791881 type Work @default.
- W4312791881 citedByCount "0" @default.
- W4312791881 crossrefType "journal-article" @default.
- W4312791881 hasAuthorship W4312791881A5022017205 @default.
- W4312791881 hasAuthorship W4312791881A5032119770 @default.
- W4312791881 hasAuthorship W4312791881A5062268518 @default.
- W4312791881 hasBestOaLocation W43127918811 @default.
- W4312791881 hasConcept C126322002 @default.
- W4312791881 hasConcept C16005928 @default.
- W4312791881 hasConcept C2776912625 @default.
- W4312791881 hasConcept C2777058396 @default.
- W4312791881 hasConcept C2779134260 @default.
- W4312791881 hasConcept C2779338263 @default.
- W4312791881 hasConcept C2779912601 @default.
- W4312791881 hasConcept C2780653079 @default.
- W4312791881 hasConcept C71924100 @default.
- W4312791881 hasConcept C90924648 @default.
- W4312791881 hasConceptScore W4312791881C126322002 @default.
- W4312791881 hasConceptScore W4312791881C16005928 @default.
- W4312791881 hasConceptScore W4312791881C2776912625 @default.
- W4312791881 hasConceptScore W4312791881C2777058396 @default.
- W4312791881 hasConceptScore W4312791881C2779134260 @default.
- W4312791881 hasConceptScore W4312791881C2779338263 @default.
- W4312791881 hasConceptScore W4312791881C2779912601 @default.
- W4312791881 hasConceptScore W4312791881C2780653079 @default.
- W4312791881 hasConceptScore W4312791881C71924100 @default.
- W4312791881 hasConceptScore W4312791881C90924648 @default.
- W4312791881 hasIssue "3" @default.
- W4312791881 hasLocation W43127918811 @default.
- W4312791881 hasOpenAccess W4312791881 @default.
- W4312791881 hasPrimaryLocation W43127918811 @default.
- W4312791881 hasRelatedWork W189440814 @default.
- W4312791881 hasRelatedWork W1976922172 @default.
- W4312791881 hasRelatedWork W2004428500 @default.
- W4312791881 hasRelatedWork W2017525966 @default.
- W4312791881 hasRelatedWork W2034523904 @default.
- W4312791881 hasRelatedWork W2077823650 @default.
- W4312791881 hasRelatedWork W2089455530 @default.
- W4312791881 hasRelatedWork W2313726973 @default.
- W4312791881 hasRelatedWork W4248195772 @default.
- W4312791881 hasRelatedWork W4315753899 @default.
- W4312791881 hasVolume "11" @default.
- W4312791881 isParatext "false" @default.
- W4312791881 isRetracted "false" @default.
- W4312791881 workType "article" @default.